Chinese vitamin C makers off the hook for U.S. antitrust violations

October 19, 2016 | BY

Katherine Jo

Following a dismissal by a U.S. appeals court of a $147 million price-fixing judgment, Chinese lawyers say that the my-government-made-me-do-it antitrust defense may not work next time for PRC companies

Share:

Last month, a three-judge panel of the U.S. Court of Appeals for the Second Circuitvacated a $147 million lower court verdict and freed a Chinese pharmaceutical maker from U.S. antitrust